Back to Search
DR. DANIEL OGAWA KENT M.D.
M.D.
Student in an Organized Health Care Education/Training Program
NPI: 1225488646Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
268347(MA)
Research & Publications (20)
The gender effect in stroke thrombolysis: of CASES, controls, and treatment-effect modification.
PMID 18495951·Neurology·2008
4-observational
Are "treatment" bare metal stents superior to "control" bare metal stents? A meta-analytic approach.
PMID 18371468·Am Heart J·2008
4-observational
Competing risk and heterogeneity of treatment effect in clinical trials.
PMID 18498644·Trials·2008
8-other
A percutaneous coronary intervention-thrombolytic predictive instrument to assist choosing between immediate thrombolytic therapy versus delayed primary percutaneous coronary intervention for acute myocardial infarction.
PMID 18328842·Am J Cardiol·2008
4-observational
Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification.
PMID 17848656·JAMA·2007
8-other
Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease.
PMID 17475813·J Am Soc Nephrol·2007
8-other
Comparison of mortality benefit of immediate thrombolytic therapy versus delayed primary angioplasty for acute myocardial infarction.
PMID 17493465·Am J Cardiol·2007
4-observational
The stroke-thrombolytic predictive instrument: a predictive instrument for intravenous thrombolysis in acute ischemic stroke.
PMID 17068305·Stroke·2006
4-observational
Can multivariable risk-benefit profiling be used to select treatment-favorable patients for thrombolysis in stroke in the 3- to 6-hour time window?
PMID 17068306·Stroke·2006
4-observational
Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials.
PMID 15569865·Stroke·2005
8-other
"Clinical-CT mismatch" and the response to systemic thrombolytic therapy in acute ischemic stroke.
PMID 16002756·Stroke·2005
8-other
In acute ischemic stroke, are asymptomatic intracranial hemorrhages clinically innocuous?
PMID 15087567·Stroke·2004
4-observational
Tissue plasminogen activator was cost-effective compared to streptokinase in only selected patients with acute myocardial infarction.
PMID 15485737·J Clin Epidemiol·2004
4-observational
Clinical trials in sub-Saharan Africa and established standards of care: a systematic review of HIV, tuberculosis, and malaria trials.
PMID 15249573·JAMA·2004
1-meta
Suitable monitoring approaches to antiretroviral therapy in resource-poor settings: setting the research agenda.
PMID 12822128·Clin Infect Dis·2003
8-other
Testing therapies less effective than the best current standard: ethical beliefs in an international sample of researchers.
PMID 14635629·Am J Bioeth·2003
8-other
Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset?
PMID 12574561·Stroke·2003
8-other
An independently derived and validated predictive model for selecting patients with myocardial infarction who are likely to benefit from tissue plasminogen activator compared with streptokinase.
PMID 12133748·Am J Med·2002
4-observational
Is primary angioplasty for some as good as primary angioplasty for all?
PMID 12472924·J Gen Intern Med·2002
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 110 FRANCIS ST, SUITE 9B
BOSTON, MA 02215 - Phone
- (617) 632-9511
Quick Facts
- NPI
- 1225488646
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile